Introduction
Liver Cirrhosis - Overview
Liver Cirrhosis - Therapeutics Development
Liver Cirrhosis - Therapeutics Assessment
Liver Cirrhosis - Companies Involved in Therapeutics Development
Liver Cirrhosis - Drug Profiles
Liver Cirrhosis - Dormant Projects
Liver Cirrhosis - Discontinued Products
Liver Cirrhosis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Liver Cirrhosis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Liver Cirrhosis - Pipeline by Advantagene Inc, H1 2020
Liver Cirrhosis - Pipeline by BIOCND Inc, H1 2020
Liver Cirrhosis - Pipeline by Bristol-Myers Squibb Co, H1 2020
Liver Cirrhosis - Pipeline by CAR-T (Shanghai) Biotechnology Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by D&D Pharmatech Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by Elixirgen Therapeutics LLC, H1 2020
Liver Cirrhosis - Pipeline by Galectin Therapeutics Inc, H1 2020
Liver Cirrhosis - Pipeline by Gilead Sciences Inc, H1 2020
Liver Cirrhosis - Pipeline by Grifols SA, H1 2020
Liver Cirrhosis - Pipeline by Gwoxi Stem Cell Applied Technology Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by Hepion Pharmaceuticals Inc, H1 2020
Liver Cirrhosis - Pipeline by International Stem Cell Corp, H1 2020
Liver Cirrhosis - Pipeline by INVENT Pharmaceuticals Inc, H1 2020
Liver Cirrhosis - Pipeline by Laekna Therapeutics Shanghai Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by LBL Biotech Corp, H1 2020
Liver Cirrhosis - Pipeline by Mina Therapeutics Ltd, H1 2020
Liver Cirrhosis - Pipeline by NGM Biopharmaceuticals Inc, H1 2020
Liver Cirrhosis - Pipeline by Novo Nordisk AS, H1 2020
Liver Cirrhosis - Pipeline by Oncocross Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by Pharmicell Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by PRISM Pharma Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by Promethera Biosciences SA, H1 2020
Liver Cirrhosis - Pipeline by Rohto Pharmaceutical Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by SCM lifescience Co Ltd, H1 2020
Liver Cirrhosis - Pipeline by Versantis AG, H1 2020
Liver Cirrhosis - Pipeline by VESSL Therapeutics Ltd, H1 2020
Liver Cirrhosis - Pipeline by Xfibra Inc, H1 2020
Liver Cirrhosis - Dormant Projects, H1 2020
Liver Cirrhosis - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Liver Cirrhosis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• Advantagene Inc
• BIOCND Inc
• Bristol-Myers Squibb Co
• CAR-T (Shanghai) Biotechnology Co Ltd
• D&D Pharmatech Co Ltd
• Elixirgen Therapeutics LLC
• Galectin Therapeutics Inc
• Gilead Sciences Inc
• Grifols SA
• Gwoxi Stem Cell Applied Technology Co Ltd
• Hepion Pharmaceuticals Inc
• International Stem Cell Corp
• INVENT Pharmaceuticals Inc
• Laekna Therapeutics Shanghai Co Ltd
• LBL Biotech Corp
• Mina Therapeutics Ltd
• NGM Biopharmaceuticals Inc
• Novo Nordisk AS
• Oncocross Co Ltd
• Pharmicell Co Ltd
• PRISM Pharma Co Ltd
• Promethera Biosciences SA
• Rohto Pharmaceutical Co Ltd
• SCM lifescience Co Ltd
• Versantis AG
• VESSL Therapeutics Ltd
• Xfibra Inc